AtriCure targets 12%-14% revenue growth in 2026 as innovation and clinical progress drive momentum
Source: SeekingAlpha
2026-02-17 19:25:37 ET
More on AtriCure
- AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript
- AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- AtriCure slides 15% after JPMorgan downgrades over Edwards competition
- Seeking Alpha’s Quant Rating on AtriCure
Read the full article on Seeking Alpha
For further details see:
AtriCure targets 12%-14% revenue growth in 2026 as innovation and clinical progress drive momentum
AtriCure Inc.
NASDAQ: ATRC
ATRC Trading
-2.04% G/L:
$29.045 Last:
311,300 Volume:
$29.81 Open:
ATRC Latest News
February 17, 2026 04:01:00 pm
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
ATRC Stock Data
$1,834,556,857
48,126,044
1.78%
78
N/A
Medical Equipment & Supplies
Healthcare
US
Mason
